https://adisinsight.springer.com/trials/700036468?error=cookies_not_supported&code=0cccbdb1-4939-4063-abb8-82e60c096a76
PegIntron [peginterferon alfa-2b]/REBETOL [ribavirin] Combination Therapy Designated Drug Use...
This study was designed to evaluate the safety and efficacy of PegIntron plus Rebetol combination therapy administered to patients with chronic hepatitis C.
combination therapyalfarebetol